Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial

N. Peters, H. Morley, S. Khalique, S. Scalzo, R. Patel, U. Gunaydin, G. Funingana, J. Evans, D. Papadatos-Pastos, U. Banjeri, B. Basu, A. Niewiarowski, S. Symeonides, F. Kelly, L. Sawretse, C. Bacon, M. Robinson, T. Gelb, S. Blakemore, N. Cook

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S117-S118
JournalEuropean Journal of Cancer
Early online date28 Oct 2022
Publication statusPublished - 28 Oct 2022

Cite this